Trademark: 79219288
Word

Status
Registered
Status Code
700
Status Date
Tuesday, October 30, 2018
Serial Number
79219288
Registration Number
5592411
Registration Date
Tuesday, October 30, 2018
Mark Type
2
Filing Date
Thursday, August 17, 2017
Published for Opposition
Tuesday, August 14, 2018

Trademark Owner History
VIVET THERAPEUTICS - Original Registrant
VIVET THERAPEUTICS, - Owner At Publication

Classifications
5 Pharmaceutical and veterinary products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; immunosuppression pharmaceutical and veterinary products; sanitary preparations for medical purposes; Biological preparations for clinical medical use intended for gene therapy and cell therapy; Clinical medical reagents used for gene therapy, genetic testing and diagnosis; Cellular preparations for medical, pharmaceutical or veterinary use for gene therapy and cell therapy; Gene therapy products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; Immunosuppression gene therapy products
44 Medical services; medical information services provided in particular via the Internet
42 Scientific research services, more particularly in the medical, biomedical, chemical, genetic, pharmaceutical, biotechnological and veterinary fields; computer programming services in the fields of science, pharmacy and medicine
The mark consists of a double helix graphic in light blue, medium blue, and dark blue with three dark blue horizontal lines between the two curves and a medium blue oval to the top right of the double helix. A gray oval shadow appears at the bottom of the mark. The color white represents background and is not a feature of the mark.
The color(s) light blue, medium blue, dark blue and gray is/are claimed as a feature of the mark.

Trademark Events
Nov 20, 2017
Assigned To Examiner
Oct 26, 2017
Sn Assigned For Sect 66a Appl From Ib
Oct 27, 2017
New Application Office Supplied Data Entered
Oct 31, 2017
Application Filing Receipt Mailed
Dec 19, 2017
Non-Final Action Written
Dec 20, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jan 9, 2018
Refusal Processed By Mpu
Jan 9, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Jan 27, 2018
Refusal Processed By Ib
Jul 6, 2018
Teas Response To Office Action Received
Jul 6, 2018
Teas/Email Correspondence Entered
Jul 6, 2018
Correspondence Received In Law Office
Jul 25, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 7, 2018
Approved For Pub - Principal Register
Mar 1, 2019
Final Decision Transaction Processed By Ib
Jul 25, 2018
Notification Of Notice Of Publication E-Mailed
Jul 25, 2018
Notification Of Possible Opposition Sent To Ib
Aug 11, 2018
Notification Processed By Ib
Aug 14, 2018
Published For Opposition
Aug 14, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 30, 2018
Registered-Principal Register
Jan 30, 2019
Final Disposition Notice Created, To Be Sent To Ib
Feb 7, 2019
Final Disposition Processed
Feb 7, 2019
Final Disposition Notice Sent To Ib
Aug 16, 2024
New Representative At Ib Received
Oct 30, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 26, 2019
Change Of Name/Address Rec'd From Ib
Nov 14, 2019
New Representative At Ib Received

Trademark Alertz updated from USPTO on 2030-01-24